HutchMED (China) LIMITED
Cash Flow Statement
| Line Item | Sep 2019 | Jun 2019 | Mar 2019 | Sep 2018 | Jun 2018 | Mar 2018 |
|---|---|---|---|---|---|---|
| Operating Activities | ||||||
| Net Income | — | — | $-19.9M | — | — | $-11.7M |
| Depreciation & Amortization | — | — | $1.2M | — | — | $834.0K |
| Depreciation | — | — | — | — | — | — |
| Amortization | — | — | — | — | — | — |
| Stock-Based Compensation | — | — | — | — | — | — |
| Net Cash from Operating Activities | $-33.5M | $-1.1M | $-28.9M | $-315.0K | $12.2M | $-30.8M |
| Investing Activities | ||||||
| Capital Expenditures | $1.8M | $2.5M | $1.4M | $1.4M | $761.0K | $1.3M |
| Business Acquisitions | — | — | — | — | — | — |
| Net Cash from Investing Activities | — | — | $33.4M | — | — | $27.7M |
| Financing Activities | ||||||
| Dividends Paid | — | — | — | — | — | — |
| Stock Repurchases | — | — | $346.0K | — | — | $5.5M |
| Net Cash from Financing Activities | — | — | $-346.0K | — | — | $-5.2M |
| Net Change in Cash | — | — | $5.7M | — | — | $-7.2M |
| Free Cash Flow | $-35.2M | $-3.6M | $-30.3M | $-1.7M | $11.5M | $-32.2M |